Chinese Network of Pediatric Antiretroviral Therapy
NCT01210924 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 400
Last updated 2018-03-30
Summary
This is an observational cohort in pediatric HIV patients in China. Children who receive antiretroviral drugs will be recruited in this study. The main objectives are as follows: 1. To establish simpler and smarter pediatric antiretroviral therapy in China including both first-line and second-line regimens. 2. To study the nature, characteristics and mechanisms of immunoreconstitution in HIV-infected children using the data and samples from the pediatric antiretroviral therapy cohort. 3. To establish a basic science and clinical research network based on the pediatric antiretroviral cohort.
Conditions
- Acquired Immunodeficiency Syndrome
Sponsors & Collaborators
-
National Center for AIDS/STD Control and Prevention, China CDC
lead OTHER_GOV
Principal Investigators
-
Fujie Zhang, MD · National Center for AIDS/STD control and prevention
Eligibility
- Max Age
- 15 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-04-30
- Primary Completion
- 2015-12-31
- Completion
- 2015-12-31
Countries
- China
Study Locations
More Related Trials
-
Outcome at 5 Years of Early Treated HIV Infected Infants in the PEDIACAM Project
NCT02043418 ·Status: ACTIVE_NOT_RECRUITING
-
Therapeutic Drug Monitoring and Viral Resistance Testing in the Treatment of HIV-Infected Children
NCT00032669 ·Status: COMPLETED ·Phase: PHASE1
-
Dual bNAb Treatment in Children
NCT03707977 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
IMPAACT P1074: Long-Term Outcomes in HIV-Infected Infants, Children, and Adolescents
NCT01061164 ·Status: COMPLETED
-
Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission
NCT02140255 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
A Treatment IND for Retrovir Brand Zidovudine (AZT) Therapy of Pediatric Patients With HIV Disease
NCT00000662 ·Status: COMPLETED ·Phase: NA
-
A Phase III Study to Evaluate the Safety, Tolerance, and Efficacy of Early Treatment With Zidovudine (AZT) in Asymptomatic Infants With HIV Infection
NCT00000750 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Ritonavir (an Anti-HIV Drug) in HIV-Positive Infants and Children
NCT00000952 ·Status: COMPLETED ·Phase: PHASE1
-
Systems Analysis and Improvement to Optimize pMTCT
NCT02023658 ·Status: COMPLETED ·Phase: NA
-
Safety and Pharmacokinetics Study of PGT121.414.LS Alone and in Combination With VRC07-523LS in Infants Exposed to HIV-1
NCT06517693 ·Status: RECRUITING ·Phase: PHASE1
-
Long-term Effects of Highly Active Anti-Retroviral Therapy on HIV-Infected Children
NCT00260806 ·Status: COMPLETED
-
UNIVERSAL 1: Pharmacokinetic Study of a Novel DTG/FTC/TAF Dose Ratio for Children
NCT05993767 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Simplified Antiretroviral Treatment Strategies in HIV Infected Children Treated by Antiretroviral (ARV) Before One Year of Age
NCT01127204 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Extended Infant Post-exposure Prophylaxis With Antiretrovirals to Reduce Postnatal HIV Transmission
NCT00115648 ·Status: COMPLETED ·Phase: PHASE3
-
Antiretroviral Regime for Viral Eradication in Newborns
NCT02712801 ·Status: COMPLETED ·Phase: PHASE4
-
Pharmacokinetics, Safety, and Efficacy of Dolutegravir Dispersible Tablets in Young Children Living With HIV
NCT05006170 ·Status: UNKNOWN ·Phase: PHASE2
-
Prenatal and Postnatal Studies of Interventions for Prevention of Mother-To-Child Transmission
NCT00028145 ·Status: COMPLETED
-
Tenofovir/Emtricitabine for PMTCT in Africa and Asia (ANRS 12109 TEmAA)
NCT00334256 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 (rCD4) in Infants and Children Infected With or at Risk for HIV Infection
NCT00000984 ·Status: COMPLETED ·Phase: PHASE1
-
Antiviral Responses to NNRTI-Based vs. PI-Based ARV Therapy in HIV Infected Infants Who Have or Have Not Received Single Dose NVP for Prevention of Mother-to-Child Transmission of HIV
NCT00307151 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacokinetics and Safety of DolutegravIr in Neonate
NCT05590325 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Evaluating the Safety and Pharmacokinetics of VRC01, VRC01LS, and VRC07-523LS, Potent Anti-HIV Neutralizing Monoclonal Antibodies, in HIV-1-Exposed Infants
NCT02256631 ·Status: COMPLETED ·Phase: PHASE1
-
When to Start Anti-HIV Drugs in Children Infected With HIV (The PREDICT Study)
NCT00234091 ·Status: COMPLETED ·Phase: PHASE3
-
Monitoring Highly Active Antiretroviral Therapy in HIV-infected Parents in Thailand
NCT00162682 ·Status: COMPLETED ·Phase: PHASE3
-
Long-Term Clinical, Immunologic, and Virologic Profiles of Children Who Received Early Treatment for HIV
NCT05154513 ·Status: COMPLETED